Compare Tetra Bio-Pharma (TBPMF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Tetra Bio-Pharma (TBPMF)

Price

$78.51

Change

-5.28%

Market Cap

$1.15B

Sector

Biotech

Biotech Sector Peers

All Biotech cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
JAZZJazz Pharmaceuticals$186.81+0.41%$11.60B
INNPFInnocanPharma$5.070.00%$354.9M
CNVCFBioHarvest Sciences$5.71+1.33%$57.1M
ZYNEZynerba Pharmaceuticals$1.30+3.17%$33.8M
XXII22nd Century Group$2.250.00%$1.1M
OVATFOvation Science$0.020.00%$623.3K

Top Matchups by Market Cap

Companies closest to Tetra Bio-Pharma in market capitalization — the most meaningful head-to-head comparisons.

TCNNFMSO

Trulieve Cannabis

MCap: $1.22B

$6.40+4.92%
Compare
CRONLP

Cronos Group

MCap: $939.0M

$2.56+0.99%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.39B

$49.38+0.48%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.44B

$74.39-0.05%
Compare
TLRYLP

Tilray Brands

MCap: $764.3M

$6.56+1.31%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Biotech sector. Compare across different business models and market segments.

SMGAncillary

Scotts Miracle-Gro

MCap: $3.55B

$63.23+0.57%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.44B

$74.39-0.05%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.39B

$49.38+0.48%
Compare

Comparing TBPMF in the Cannabis Market

Tetra Bio-Pharma (TBPMF) is a Biotech-sector cannabis company trading at $78.51 per share with a market capitalization of $1.15B. Among its Biotech peers, TBPMF ranks #2 by market cap, with trailing twelve-month revenue of $1.24B and a gross margin of 33.7%. The stock has moved -5.28% in the current session, trading on the OTC exchange.

When comparing TBPMF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (4.7x), revenue growth (-29.20% YoY), and balance sheet strength (cash of $73.0M vs. debt of $384.2M). The comparison tables above allow you to evaluate Tetra Bio-Pharma relative to 6 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does TBPMF compare to other Biotech stocks?+
Tetra Bio-Pharma has a market cap of $1.15B, placing it among 7 companies in the Biotech sector. Its price-to-sales ratio is 4.7x and its gross margin is 33.7%. Use the table above to compare these metrics against every Biotech peer.
What is TBPMF's biggest competitor?+
By market capitalization, the closest comparable company is Trulieve Cannabis (TCNNF) with a market cap of $1.22B. Click the compare link to view a full head-to-head analysis.
Is TBPMF overvalued compared to its peers?+
Tetra Bio-Pharma trades at a P/S ratio of 4.7x. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than TBPMF?+
Tetra Bio-Pharma has a gross margin of 33.7%. Among its Biotech peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare TBPMF to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Biotech. You can click any company to see a full side-by-side comparison with TBPMF covering price, valuation, financials, and growth metrics.

All TBPMF Comparisons

Every available head-to-head comparison for Tetra Bio-Pharma.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.